Irinotecan hydrochloride (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Irinotecan hydrochloride drug offered from Actavis Pharma, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Irinotecan hydrochloride |
| SUBSTANCE NAME: | IRINOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-01-05 |
| END MARKETING DATE: | 0000-00-00 |
Irinotecan hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Irinotecan hydrochloride from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2015-01-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45963-614_c954ef1f-225e-4fcb-9f0c-0a152e69f5cd |
| PRODUCT NDC: | 45963-614 |
| APPLICATION NUMBER: | ANDA078589 |
Other IRINOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
